Contrast-Enhanced Ultrasound No Aid for Metastasis DetectionLast Updated: December 15, 2017. Contrast-enhanced laparoscopic ultrasonography does not appear to increase the detection rate of liver metastasis during robotic-assisted surgery for primary colorectal cancer, according to a study published online Nov. 13 in the Journal of Clinical Ultrasound.
FRIDAY, Dec. 15, 2017 (HealthDay News) -- Contrast-enhanced laparoscopic ultrasonography (CE-LUS) does not appear to increase the detection rate of liver metastasis during robotic-assisted surgery for primary colorectal cancer (CRC), according to a study published online Nov. 13 in the Journal of Clinical Ultrasound.
Signe Bremholm Ellebæk, M.D., from Odense University Hospital in Denmark, and colleagues assessed the potential clinical value of CE-LUS as a screening tool for liver metastases during robotic-assisted surgery for primary CRC among 50 consecutive patients.
The researchers found that patients were equally distributed between stage I, II, and III classification. CE-LUS did not detect any liver metastasis, as was confirmed by follow-up using contrast-enhanced computed tomography imaging at three and 12 months postoperatively. CE-LUS was easy to perform and no complications were reported.
"The use of CE-LUS as a screening modality for detection of liver metastasis cannot be recommended based on this study, but larger controlled studies on high-risk patients seem relevant," the authors write.
|Previous: Majority of Women Prefer Non-Invasive Testing for Trisomy 21||Next: Expanded TIMI Risk Score Deemed Practical in Diabetes|
Reader comments on this article are listed below. Review our comments policy.